Michigan Cancer Consortium

Michigan Cancer ConsortiumThe Barbara Ann Karmanos Cancer Institute is a member of the Michigan Cancer Consortium.

The MCC is a statewide, broad-based partnership that strives to include all interested public and private organizations and provides a forum for collaboration to reduce the burden of cancer among the citizens of Michigan by achieving the Consortium's research-based and results-oriented cancer prevention and control priorities. For more information visit the MCC website

Goals of Consortium and its members include:

  • Prevent cancer from occurring
  • Promote early detection of cancer using tests that have been shown to reduce mortality
  • Diagnose and treat all patients using the most effective and appropriate methods
  • Optimize quality of life for every person affected by cancer

The Latest From Karmanos Cancer Institute

News

Have 10 Minutes? Here’s What You Need to Know About Cancer Clinical Trials

Did you know that a cancer clinical trial is a research study that examines new cancer-fighting drugs, surgical methods, diagnostic tests, or meth...

Read More

Karmanos Nurse’s Own Breast Cancer Experience Makes All the Difference in Caring for Patients

Angela Gushow, RN, OCN, oncology nurse at Karmanos Cancer Institute at McLaren Bay Region and Auburn resident, has been caring for cancer patients...

Read More

Decades of Support in Gratitude: The Purtans

Gail Purtan suffered from metastatic ovarian cancer for the better part of two decades, and it was because of her diagnosis that the Purtans becam...

Read More
News

WWJ | ‘Houses with Roofs Caved In’: Karmanos Surgeon Explains Stage 0 Breast Cancer (DCIS)

Listen Now

WWJ | Treatment Plans, Clinical Trials and Second Opinions: Navigating a Breast Cancer Diagnosis

Listen Now

Sunday Edition | Second Opinions, Clinical Trials and Second Opinions in Breast Cancer

Listen Now